New stroke device shows promise in small trial
NCT ID NCT05107206
First seen Apr 30, 2026 · Last updated May 14, 2026 · Updated 3 times
Summary
This study tested a new device called Envi-SR for treating acute ischemic stroke, which happens when a blood clot blocks blood flow to the brain. The trial compared the Envi-SR to other FDA-cleared devices in 12 adults who had a stroke and could be treated within 24 hours. The goal was to see if the new device helps more people recover with little or no disability and causes fewer bleeding complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advocate Aurora Health
Downers Grove, Illinois, 60068, United States
-
Baptist Health Research Institute
Jacksonville, Florida, 32207, United States
-
North Shore University Hospital
Manhasset, New York, 11030, United States
-
Providence Medical Foundation
Irvine, California, 92612, United States
Conditions
Explore the condition pages connected to this study.